AbCellera Biologics - ABCL Net Assets per Single Share

Graphic logo of AbCellera Corp (ABCL)

AbCellera Biologics (ABCL) leads the immunology sector by developing advanced AI systems for rapid antibody analysis and the generation of unique molecules. The business's environmental focus is evident in its energy-efficient computing and the minimization of chemical waste. Market dynamics for the securities, where the indicator stands at 2.91, are supplemented by the use of third-party cloud services and partner research outsourcing to accelerate drug development.

AbCellera (ABCL): Share Book Value from 07/04/2022 to 10/27/2026

AbCellera Bio - analytical breakdowns and key metrics (ABCL)

- price and consensus price forecast:
Stock Price AbCellera Biologics Inc|ABCL - Consensus Target
- market capitalization data:
Market Value AbCellera Biologics Inc.|ABCL - Total Company Value
- book capitalization data:
Net Assets per Single Share AbCellera|ABCL - Net Asset Value|Market Capitalization to Book Value Ratio abcellera.com|ABCL - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital AbCellera Biologics|ABCL - Long-Term Debt to Capital|Short-Term Debt to Equity AbCellera Biologics|ABCL - Aggregate Debt Obligations|Debt to Book Capitalization Ratio AbCellera Biologics Inc.
Fundamental company valuation:AbCellera - ABCL
Manufactured products of AbCellera Biologics

The price action of AbCellera Biologics (ABCL) reflects the actual capitalization of assets amid fierce competition with AI labs and major CROs. The reported book value per share captures the actual net asset value attributable to a single security. This metric is calculated by dividing total equity by the total number of shares outstanding. For the biotechnology sector, this serves as the primary barrier protecting capital from market optimism. Growth in this metric confirms the business's material stability amidst the struggle for pharma partnerships.

Competitors of AbCellera Biologics (ABCL)

ARGX: Book Value per Share|BNTX: Accounting Value per Share|Abivax Corp (ABVX) - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Single Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|enGene Bio - Book Value per Share|RAPT - Book Value per Share|aerovatetx.com (JBIO) - Book Value per Share|aclaristx.com (ACRS) - Net Assets per Single Share|Book Value per Share KYTX|Accounting Value per Share Tiziana Life Sciences Ltd.|Cabaletta Bio, Inc - Book Value per Share|Net Asset Value per Share VTYX (Ventyx Biosciences, Inc)|Net Assets per Single Share Theratechnologies Inc. THTX|avalotx.com - Net Assets per Single Share|ELDN - Net Assets per Single Share|AGEN - Net Assets per Single Share|Book Value per Share CLYM|ZURA (Zura Bio Ltd) - Net Asset Value per Share|ATYR - Net Assets per Single Share|Accounting Value of a Share Adagene Corp|Book Value per Share IMA|Book Value per Share shattucklabs.com STTK|Accounting Value per Share Equillium|Accounting Value of a Share Connect Biopharma Holdings CNTB|IMUX - Book Value per Share|ATRA - Net Assets per Single Share|inflarx.de - Book Value per Share|XFOR (X4 Pharmaceuticals Inc.) - Net Assets per Share|Net Assets per Single Share ACET (Adicet Bio Inc.)|Net Asset Value per Share CELU|Net Assets per Single Share INmune Bio, Inc. (INMB)|Net Assets per Single Share BRNS (barinthusbio.com)|KZR: Net Assets per Single Share|Net Asset Value per Share SAB Biotherapeutics Inc. SABS|Book Value per Share AKTX|ENLV - Book Value of One Share|q32bio.com - Book Value per Share|geovax.com (GOVX) - Net Assets per Share|Book Value per Share EDSA|Accounting Value per Share IBIO|CARM (Carisma Therapeutics) - Net Assets per Single Share|Net Assets per Share XTL Bio (XTLB)|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|Book Value per Share HCW Biologics, Inc. HCWB|APVO - Book Value per Share|AIM - Net Assets per Single Share|ADTX (aditxt.com) - Book Value per Share|GRI (GRI Bio Corporation) - Accounting Value per Share|Net Assets per Single Share XORTX Therapeutics Inc.|Net Assets per Single Share HIND|REVB - Net Assets per Single Share|Share Book Value Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com HOOK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com THRD